5 结果
FIELD OF INVENTION
The invention in general relates to medicaments for obesity management. More specifically, it relates to anti-obesity potential of Calebin A.
DESCRIPTION OF PRIOR ART
Obesity is the most prevalent nutritional disorder in industrialized countries and is a growing problem in
FIELD OF INVENTION
The invention in general relates to medicaments for obesity management. More specifically, it relates to anti-obesity potential of Calebin A.
DESCRIPTION OF PRIOR ART
Obesity is the most prevalent nutritional disorder in industrialized countries and is a growing problem in
The present invention relates to a novel therapeutic use of L-acetylcarnitine, L-isovalerylcarnitine, L-propionylcarnitine or pharmacologically acceptable salts thereof for increasing the levels of IGF-1(insulin-like growth factor 1) for the therapeutic treatment or prophylaxis or cytological
This is a 371 of PCT/IT97/00113 filed May 15, 1997.
The present invention relates to a novel therapeutic use of L-acetylcarnitine, L-isovalerylcarnitine, L-propionylcarnitine or pharmacologically acceptable salts thereof for increasing the levels of IGF-1 (insulin-like growth factor 1) for the
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to a novel therapeutic use of L-acetylcarnitine, L-isovalerylcarnitine, L-propionylcarnitine or pharmacologically acceptable salts thereof for increasing the levels of IGF-1 (insulin-like growth factor 1) for the